- Home
- RVPH vs XBP Comparison
RVPH vs XBP Comparison
Compare RVPH & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- XBP
- Stock Information
- Founded
- RVPH 2006
- XBP N/A
- Country
- RVPH United States
- XBP United Kingdom
- Employees
- RVPH N/A
- XBP N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- XBP Business Services
- Sector
- RVPH Health Care
- XBP Consumer Discretionary
- Exchange
- RVPH Nasdaq
- XBP Nasdaq
- Market Cap
- RVPH 33.4M
- XBP 27.8M
- IPO Year
- RVPH N/A
- XBP N/A
- Fundamental
- Price
- RVPH $1.22
- XBP $1.31
- Analyst Decision
- RVPH Strong Buy
- XBP
- Analyst Count
- RVPH 4
- XBP 0
- Target Price
- RVPH $15.33
- XBP N/A
- AVG Volume (30 Days)
- RVPH 661.2K
- XBP 1.9M
- Earning Date
- RVPH 11-14-2024
- XBP 11-12-2024
- Dividend Yield
- RVPH N/A
- XBP N/A
- EPS Growth
- RVPH N/A
- XBP N/A
- EPS
- RVPH N/A
- XBP N/A
- Revenue
- RVPH N/A
- XBP $157,146,000.00
- Revenue This Year
- RVPH N/A
- XBP N/A
- Revenue Next Year
- RVPH N/A
- XBP N/A
- P/E Ratio
- RVPH N/A
- XBP N/A
- Revenue Growth
- RVPH N/A
- XBP N/A
- 52 Week Low
- RVPH $0.60
- XBP $0.84
- 52 Week High
- RVPH $5.67
- XBP $47.40
- Technical
- Relative Strength Index (RSI)
- RVPH 52.82
- XBP 57.04
- Support Level
- RVPH $1.09
- XBP $1.20
- Resistance Level
- RVPH $1.37
- XBP $1.60
- Average True Range (ATR)
- RVPH 0.15
- XBP 0.16
- MACD
- RVPH 0.03
- XBP 0.03
- Stochastic Oscillator
- RVPH 58.77
- XBP 61.64
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About XBP XBP Europe Holdings Inc.
XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.